Vaxart Historical Balance Sheet

VXRT Stock

USD 0.68 0.04 5.58%

Trend analysis of Vaxart Inc balance sheet accounts such as Total Assets of 150.6 M, Short Long Term Debt Total of 29.3 M, Other Current Liabilities of 9.8 M or Total Current Liabilities of 17.6 M provides information on Vaxart's total assets, liabilities, and equity, which is the actual value of Vaxart Inc to its prevalent stockholders. By breaking down trends over time using Vaxart balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Vaxart Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vaxart Inc is a good buy for the upcoming year.

Vaxart Inventory

0.86

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Vaxart Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Vaxart Inc at a specified time, usually calculated after every quarter, six months, or one year. Vaxart Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Vaxart and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Vaxart currently owns. An asset can also be divided into two categories, current and non-current.

Vaxart Balance Sheet Chart

At this time, Vaxart's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 27.5 M in 2025, despite the fact that Retained Earnings are likely to grow to (350.2 M).

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Vaxart assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vaxart Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Vaxart balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Vaxart Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Vaxart's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Vaxart Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	21.7M	26.5M	23.9M	29.3M
Total Assets	153.8M	91.8M	105.6M	150.6M

Short Long Term Debt Total Total Assets

Vaxart balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock Total Equity	Common Stock
Total Assets		0.21	0.29	0.45	0.97	0.55	-0.61	-0.5	0.81	0.67	0.39	0.89	-0.11	0.65	0.42	-0.18	0.8	0.67	0.65	0.43	0.92	0.25	0.08	0.03	-0.56	-0.41
Short Long Term Debt Total	0.21		-0.09	0.01	0.09	0.63	0.39	-0.71	-0.19	0.51	0.52	-0.04	-0.43	0.65	0.47	0.0	0.4	0.66	0.46	0.61	-0.02	0.59	-0.08	-0.23	-0.48	-0.39
Other Current Liab	0.29	-0.09		0.79	0.3	0.02	-0.25	0.07	0.27	0.05	-0.15	0.24	0.63	0.0	-0.3	-0.1	0.03	0.06	0.12	-0.03	0.34	-0.09	-0.24	-0.22	-0.05	0.06
Total Current Liabilities	0.45	0.01	0.79		0.43	0.34	-0.18	-0.17	0.28	0.3	0.05	0.28	0.61	0.26	-0.23	-0.14	0.32	0.22	0.3	0.23	0.4	0.11	-0.2	0.22	-0.3	-0.22
Total Stockholder Equity	0.97	0.09	0.3	0.43		0.44	-0.71	-0.34	0.86	0.58	0.32	0.93	-0.01	0.52	0.26	-0.15	0.73	0.52	0.48	0.33	0.95	0.09	0.07	0.12	-0.51	-0.35
Property Plant And Equipment Net	0.55	0.63	0.02	0.34	0.44		0.24	-0.88	0.04	0.9	0.79	0.19	-0.32	0.92	0.49	0.15	0.7	0.87	0.66	0.88	0.22	0.78	0.04	-0.03	-0.76	-0.68
Net Debt	-0.61	0.39	-0.25	-0.18	-0.71	0.24		-0.2	-0.95	0.07	0.29	-0.87	-0.15	0.12	-0.01	0.3	-0.21	0.06	-0.11	0.23	-0.84	0.4	-0.03	-0.13	-0.06	-0.19
Retained Earnings	-0.5	-0.71	0.07	-0.17	-0.34	-0.88	-0.2		-0.08	-0.76	-0.6	-0.2	0.41	-0.87	-0.72	0.16	-0.59	-0.95	-0.79	-0.86	-0.22	-0.85	0.01	0.28	0.56	0.49
Cash	0.81	-0.19	0.27	0.28	0.86	0.04	-0.95	-0.08		0.2	-0.11	0.95	0.05	0.19	0.2	-0.32	0.45	0.25	0.34	0.05	0.94	-0.11	0.05	0.08	-0.18	-0.03
Non Current Assets Total	0.67	0.51	0.05	0.3	0.58	0.9	0.07	-0.76	0.2		0.76	0.33	-0.34	0.91	0.51	0.06	0.75	0.83	0.66	0.8	0.34	0.66	0.37	-0.13	-0.83	-0.84
Non Currrent Assets Other	0.39	0.52	-0.15	0.05	0.32	0.79	0.29	-0.6	-0.11	0.76		0.15	-0.53	0.66	0.48	0.5	0.53	0.6	0.5	0.48	0.12	0.42	0.19	-0.01	-0.6	-0.59
Cash And Short Term Investments	0.89	-0.04	0.24	0.28	0.93	0.19	-0.87	-0.2	0.95	0.33	0.15		-0.07	0.28	0.31	-0.2	0.57	0.35	0.45	0.09	0.98	-0.11	0.01	0.1	-0.25	-0.08
Net Receivables	-0.11	-0.43	0.63	0.61	-0.01	-0.32	-0.15	0.41	0.05	-0.34	-0.53	-0.07		-0.4	-0.77	-0.24	-0.34	-0.4	-0.44	-0.26	0.03	-0.35	-0.38	0.25	0.29	0.32
Common Stock Shares Outstanding	0.65	0.65	0.0	0.26	0.52	0.92	0.12	-0.87	0.19	0.91	0.66	0.28	-0.4		0.57	-0.01	0.77	0.94	0.69	0.9	0.33	0.84	0.18	-0.16	-0.81	-0.76
Non Current Liabilities Total	0.42	0.47	-0.3	-0.23	0.26	0.49	-0.01	-0.72	0.2	0.51	0.48	0.31	-0.77	0.57		-0.1	0.46	0.71	0.86	0.4	0.26	0.53	0.27	-0.42	-0.27	-0.28
Inventory	-0.18	0.0	-0.1	-0.14	-0.15	0.15	0.3	0.16	-0.32	0.06	0.5	-0.2	-0.24	-0.01	-0.1		-0.11	-0.14	-0.17	-0.1	-0.23	-0.04	-0.09	0.22	-0.07	0.0
Other Current Assets	0.8	0.4	0.03	0.32	0.73	0.7	-0.21	-0.59	0.45	0.75	0.53	0.57	-0.34	0.77	0.46	-0.11		0.7	0.62	0.6	0.62	0.45	0.12	0.13	-0.75	-0.61
Other Stockholder Equity	0.67	0.66	0.06	0.22	0.52	0.87	0.06	-0.95	0.25	0.83	0.6	0.35	-0.4	0.94	0.71	-0.14	0.7		0.82	0.84	0.39	0.82	0.06	-0.34	-0.64	-0.56
Total Liab	0.65	0.46	0.12	0.3	0.48	0.66	-0.11	-0.79	0.34	0.66	0.5	0.45	-0.44	0.69	0.86	-0.17	0.62	0.82		0.52	0.47	0.58	0.16	-0.29	-0.42	-0.39
Property Plant And Equipment Gross	0.43	0.61	-0.03	0.23	0.33	0.88	0.23	-0.86	0.05	0.8	0.48	0.09	-0.26	0.9	0.4	-0.1	0.6	0.84	0.52		0.12	0.89	0.04	-0.14	-0.72	-0.64
Total Current Assets	0.92	-0.02	0.34	0.4	0.95	0.22	-0.84	-0.22	0.94	0.34	0.12	0.98	0.03	0.33	0.26	-0.23	0.62	0.39	0.47	0.12		-0.06	-0.06	0.11	-0.28	-0.09
Short Term Debt	0.25	0.59	-0.09	0.11	0.09	0.78	0.4	-0.85	-0.11	0.66	0.42	-0.11	-0.35	0.84	0.53	-0.04	0.45	0.82	0.58	0.89	-0.06		0.07	-0.29	-0.61	-0.54
Intangible Assets	0.08	-0.08	-0.24	-0.2	0.07	0.04	-0.03	0.01	0.05	0.37	0.19	0.01	-0.38	0.18	0.27	-0.09	0.12	0.06	0.16	0.04	-0.06	0.07		-0.25	-0.38	-0.66
Accounts Payable	0.03	-0.23	-0.22	0.22	0.12	-0.03	-0.13	0.28	0.08	-0.13	-0.01	0.1	0.25	-0.16	-0.42	0.22	0.13	-0.34	-0.29	-0.14	0.11	-0.29	-0.25		-0.03	0.07
Common Stock Total Equity	-0.56	-0.48	-0.05	-0.3	-0.51	-0.76	-0.06	0.56	-0.18	-0.83	-0.6	-0.25	0.29	-0.81	-0.27	-0.07	-0.75	-0.64	-0.42	-0.72	-0.28	-0.61	-0.38	-0.03		0.84
Common Stock	-0.41	-0.39	0.06	-0.22	-0.35	-0.68	-0.19	0.49	-0.03	-0.84	-0.59	-0.08	0.32	-0.76	-0.28	0.0	-0.61	-0.56	-0.39	-0.64	-0.09	-0.54	-0.66	0.07	0.84

Click cells to compare fundamentals

Vaxart Account Relationship Matchups

Vaxart balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	152.6M	221.2M	153.8M	91.8M	105.6M	150.6M
Short Long Term Debt Total	7.2M	13.0M	21.7M	26.5M	23.9M	29.3M
Other Current Liab	7.6M	5.9M	8.2M	5.6M	5.1M	9.8M
Total Current Liabilities	11.8M	10.8M	17.9M	13.7M	12.4M	17.6M
Total Stockholder Equity	123.4M	187.5M	110.6M	57.8M	66.5M	89.3M
Property Plant And Equipment Net	8.3M	19.8M	41.3M	36.6M	32.9M	27.5M
Net Debt	(119.7M)	(130.7M)	(22.3M)	(8.2M)	(7.4M)	(7.8M)
Retained Earnings	(148.9M)	(219.4M)	(327.1M)	(409.6M)	(368.6M)	(350.2M)
Cash	126.9M	143.7M	44.0M	34.8M	40.0M	52.2M
Non Current Assets Total	24.1M	52.0M	54.4M	46.3M	41.7M	40.4M
Non Currrent Assets Other	372K	890K	3.6M	926K	833.4K	791.7K
Cash And Short Term Investments	126.9M	166.5M	93.7M	39.7M	45.7M	61.2M
Net Receivables	334K	71K	20K	3.0M	2.7M	2.6M
Common Stock Shares Outstanding	88.3M	121.5M	127.7M	144.8M	166.5M	174.9M
Liabilities And Stockholders Equity	152.6M	221.2M	153.8M	91.8M	105.6M	150.6M
Non Current Liabilities Total	17.4M	22.9M	25.3M	20.3M	18.3M	27.5M
Other Current Assets	2.4M	5.2M	3.7M	2.8M	2.5M	4.7M
Other Stockholder Equity	272.3M	406.9M	438.0M	467.4M	537.5M	564.3M
Total Liab	29.2M	33.6M	43.3M	34.0M	30.6M	44.6M
Property Plant And Equipment Gross	8.3M	19.8M	15.6M	43.4M	39.1M	24.7M
Total Current Assets	128.5M	169.2M	99.5M	45.5M	52.4M	95.0M
Short Term Debt	2.1M	1.0M	2.3M	6.5M	5.9M	6.1M
Intangible Assets	15.4M	10.6M	5.0M	4.3M	3.9M	3.7M
Accounts Payable	2.1M	3.9M	5.5M	1.6M	1.4M	1.4M
Common Stock Total Equity	714K	4.8M	11K	13K	11.7K	11.1K
Common Stock	5K	11K	13K	15K	13.5K	12.8K
Current Deferred Revenue	4.2M	5.1M	2M	(1.1M)	(952.2K)	(904.6K)
Other Liab	13.4M	14.9M	10.9M	5.9M	6.7M	7.9M
Net Tangible Assets	13.0M	123.4M	187.5M	110.6M	127.2M	67.4M
Other Assets	141K	372K	890K	3.6M	4.1M	4.3M
Retained Earnings Total Equity	(116.7M)	(148.9M)	(219.4M)	(327.1M)	(294.4M)	(279.7M)
Capital Surpluse	124.8M	272.3M	406.9M	438.0M	503.7M	528.9M
Property Plant Equipment	210K	1.5M	6.6M	15.6M	17.9M	18.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vaxart Historical Balance Sheet

Vaxart Inventory

0.86

About Vaxart Balance Sheet Analysis

Vaxart Balance Sheet Chart

Total Assets

Total Current Liabilities

Vaxart balance sheet Correlations

Vaxart Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vaxart balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Vaxart Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 0.98	Cash And Short Term Investments
Total Stockholder Equity	+ 0.97	Total Assets
Total Current Assets	+ 0.95	Total Stockholder Equity
Cash And Short Term Investments	+ 0.95	Cash
Total Current Assets	+ 0.94	Cash
Other Stockholder Equity	+ 0.94	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.95	Retained Earnings
Cash	- 0.95	Net Debt
Retained Earnings	- 0.88	Property Plant And Equipment Net
Common Stock Shares Outstanding	- 0.87	Retained Earnings
Cash And Short Term Investments	- 0.87	Net Debt
Property Plant And Equipment Gross	- 0.86	Retained Earnings